Waters Corporation $WAT Shares Bought by Robeco Institutional Asset Management B.V.

Key Points

• Robeco Institutional Asset Management B.V. increased its stake in Waters Corporation by 16.3% to 515,495 shares, valued at approximately $179.93 million, as reported to the SEC.
• Waters Corporation reported a quarterly EPS of $2.95, beating estimates by $0.02, with revenue of $771.33 million, a year-over-year increase of 8.8%.
• Wall Street analysts maintain a consensus rating of "Moderate Buy" for Waters stock, with an average price target of $380.43.

Robeco Institutional Asset Management B.V. raised its position in Waters Corporation (NYSE:WAT - Free Report) by 16.3% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 515,495 shares of the medical instruments supplier's stock after buying an additional 72,174 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.87% of Waters worth $179,928,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of WAT. Olde Wealth Management LLC acquired a new position in Waters in the 1st quarter valued at $25,000. Zions Bancorporation National Association UT acquired a new position in Waters in the 1st quarter valued at $28,000. IFP Advisors Inc increased its stake in Waters by 118.9% in the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock valued at $30,000 after buying an additional 44 shares during the period. Whipplewood Advisors LLC increased its stake in Waters by 5,200.0% in the 1st quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock valued at $39,000 after buying an additional 104 shares during the period. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Waters in the 1st quarter valued at $41,000. 94.01% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Jefferies Financial Group set a $385.00 target price on shares of Waters and gave the stock a "buy" rating in a research report on Monday, August 4th. Wall Street Zen lowered shares of Waters from a "buy" rating to a "hold" rating in a research report on Saturday, July 26th. Bank of America boosted their target price on shares of Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Robert W. Baird decreased their target price on shares of Waters from $374.00 to $352.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 16th. Finally, Wells Fargo & Company decreased their target price on shares of Waters from $330.00 to $315.00 and set an "equal weight" rating on the stock in a research report on Tuesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and eight have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $380.43.

Waters Price Performance

Waters stock opened at $319.80 on Thursday. Waters Corporation has a 52 week low of $275.05 and a 52 week high of $423.56. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The firm's 50-day simple moving average is $295.93 and its 200 day simple moving average is $326.36. The firm has a market capitalization of $19.03 billion, a PE ratio of 28.84, a P/E/G ratio of 2.80 and a beta of 1.04.

Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, topping the consensus estimate of $2.93 by $0.02. Waters had a net margin of 21.71% and a return on equity of 38.60%. The business had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. During the same period in the previous year, the firm earned $2.63 EPS. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. On average, equities research analysts predict that Waters Corporation will post 12.86 EPS for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.